Lower risk treatment for blood clots 'empowers' patients, improves care

Emergency department researchers at the Indiana University School of Medicine found positive results and cost savings from treating patients with potentially fatal blood clots with rivaroxaban verses heparin and warfarin.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1MemYvV